focus -WSS

focus

author：Wikipedia 2025-10-02 01:07:15 - browse：247

Adobe

More than a year ago, Kaiser Permanente made waves when it said it was creating a new, sprawling entity of nonprofit hospitals and doctors with Geisinger as its first takeover — the latest example of health care companies bulking up in an already highly consolidated industry.

Nothing has happened since then, at least publicly. Geisinger’s 10 hospitals and 1,700 employed physicians are now officially part of the group, known as Risant Health. Kaiser, which is both a health insurance company and a network of providers, said it wants to add at least five to six more health systems by 2028.

Those other organizations are still a mystery. But recent financial reports show a handful of systems that have been on the same shaky trajectory as Geisinger and could find themselves in Kaiser’s crosshairs. Patients and local communities have a lot at stake if their health system gets gobbled up by Kaiser; it’s still unclear how this unique structure will alter costs or quality of care.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

focus

WSS

Health AI adoption puts security, privacy startups on investors' radar

New brain studies show LSD's effects on the brain in full color

Medicare Advantage today, explained in one chart

Leading voice in opioid treatment defends methadone clinic system

Physicians and social media: If you see something, say something?

U.K. researchers warn about biases in medical devices, algorithms

knowledge

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

Dewpoint Therapeutics lays off staff after losing partnerships

Hepatitis C has a cure — but many Americans still lack access to it

Medicare Advantage today, explained in one chart

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AstraZeneca to buy developer of next

Drug repurposing or repositioning? The language matters

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Moonlake's readout produced a cash windfall. Risks remain

Why doctors need education on FDA device approval process

focus

Physicians and social media: If you see something, say something?

Dewpoint Therapeutics lays off staff after losing partnerships

Health AI adoption puts security, privacy startups on investors' radar

How digital therapeutics firms are pivoting after Pear's bankruptcy

Research misconduct: Proposed new rules face resistance

Readout Newsletter: Merck, J&J, and long Covid

hotspot

focus

hotspot

hotspot